Like all FDA approved drugs, Provenge is finally seeing the light of day after nearly a decade of development and testing.

"The exciting thing is that it's the first one ever to show benefit in people that have cancer," Trump says.

But this medicine is only for men with advanced prostate cancer. And it's not a traditional vaccine. Doctors take blood from a patient and purifies it to find a person's naturally immune cells. Using those and the Provenge formula, Roswell doctors can craft a customized vaccine.

"In this case you actually have to take a patient's own material, send it to a central distribution place, have it manipulated and then receive it back, so it's a much more complicated implementation process," Trump says.

While FDA has recognized the drug's benefit, Trump says the overall results are modest.

"It's far from the magic bullet or the cure-all. But there's no doubt, those men that get this vaccine live longer than those men that didn't get the vaccine," Trump says.

Roswell Park will stage further clinical trials to observe how the vaccine with other treatments.